DK0571485T3 - 3-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende disse forbindelser - Google Patents

3-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende disse forbindelser

Info

Publication number
DK0571485T3
DK0571485T3 DK92905173.8T DK92905173T DK0571485T3 DK 0571485 T3 DK0571485 T3 DK 0571485T3 DK 92905173 T DK92905173 T DK 92905173T DK 0571485 T3 DK0571485 T3 DK 0571485T3
Authority
DK
Denmark
Prior art keywords
compounds
pct
oxatriazole
substituted
pharmaceutical preparation
Prior art date
Application number
DK92905173.8T
Other languages
English (en)
Inventor
Gunnar Leo Karup
Herbert Fritz Preikschat
Tim Niss Corell
Bodil Gyllembourg Lissau
Finn Priess Clausen
Soeren Bols Petersen
Boerge Ingvar Frisch Alhede
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Application granted granted Critical
Publication of DK0571485T3 publication Critical patent/DK0571485T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK92905173.8T 1991-02-12 1992-02-11 3-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende disse forbindelser DK0571485T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK023891A DK23891D0 (da) 1991-02-12 1991-02-12 3-substituerede 1,2,3,4-oxa-triazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende disse forbindelser
JP4071309A JPH05286950A (ja) 1991-02-12 1992-03-27 ３−置換１，２，３，４−オキサトリアゾール−５−イミン化合物およびその製造方法

Publications (1)

Publication Number Publication Date
DK0571485T3 true DK0571485T3 (da) 1994-10-17

Family

ID=26063591

Family Applications (2)

Application Number Title Priority Date Filing Date
DK023891A DK23891D0 (da) 1991-02-12 1991-02-12 3-substituerede 1,2,3,4-oxa-triazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende disse forbindelser
DK92905173.8T DK0571485T3 (da) 1991-02-12 1992-02-11 3-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende disse forbindelser

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK023891A DK23891D0 (da) 1991-02-12 1991-02-12 3-substituerede 1,2,3,4-oxa-triazol-5-iminforbindelser og fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat indeholdende disse forbindelser

Country Status (23)

Country Link
US (1) US5405857A (da)
EP (1) EP0571485B1 (da)
JP (1) JPH05286950A (da)
AT (1) ATE111455T1 (da)
BG (1) BG97988A (da)
BR (1) BR9205624A (da)
CA (1) CA2100160A1 (da)
CZ (1) CZ163993A3 (da)
DE (1) DE69200412T2 (da)
DK (2) DK23891D0 (da)
ES (1) ES2062891T3 (da)
FI (1) FI933543L (da)
HU (1) HUT68643A (da)
IE (1) IE66384B1 (da)
LT (1) LT3184B (da)
LV (1) LV10617B (da)
NO (1) NO932822D0 (da)
PL (1) PL169685B1 (da)
PT (1) PT100121A (da)
RO (1) RO111190B1 (da)
SI (1) SI9210142A (da)
SK (1) SK78993A3 (da)
WO (1) WO1992013847A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4321109C2 (de) * 1993-06-25 1998-01-29 Sanol Arznei Schwarz Gmbh Pharmakologisch aktive Verbindungen mit Nitrosohydrazinpartialstruktur
MX9504230A (es) * 1994-10-07 1997-03-29 Gea Farmaceutisk Fabrik As Compuestos de 1,2,3,4-oxatriazol-5-imina sustituidos en las posiciones 3 y 5, proceso para la preparacion de los mismos, preparacion farmaceutica que contiene dichos compuestos y el uso de los mismos para la preparacion de medicamentos.
US8029893B2 (en) 2004-04-02 2011-10-04 Curwood, Inc. Myoglobin blooming agent, films, packages and methods for packaging
US8741402B2 (en) * 2004-04-02 2014-06-03 Curwood, Inc. Webs with synergists that promote or preserve the desirable color of meat
US8053047B2 (en) 2004-04-02 2011-11-08 Curwood, Inc. Packaging method that causes and maintains the preferred red color of fresh meat
US8470417B2 (en) 2004-04-02 2013-06-25 Curwood, Inc. Packaging inserts with myoglobin blooming agents, packages and methods for packaging
US8545950B2 (en) * 2004-04-02 2013-10-01 Curwood, Inc. Method for distributing a myoglobin-containing food product
US8110259B2 (en) 2004-04-02 2012-02-07 Curwood, Inc. Packaging articles, films and methods that promote or preserve the desirable color of meat
US7867531B2 (en) 2005-04-04 2011-01-11 Curwood, Inc. Myoglobin blooming agent containing shrink films, packages and methods for packaging
CA2749163A1 (en) * 2009-01-14 2010-07-22 The Salk Institute For Biological Studies Methods for screening and compounds that protect against amyloid diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2015878B (en) * 1978-03-10 1982-05-26 Shell Int Research Biocidal compositions
US4239355A (en) 1979-02-05 1980-12-16 Vought Corporation Visual simulator projection system
US4329355A (en) * 1979-03-01 1982-05-11 Henry David W Mesoionic antitumor compositions and methods for using the same in the treatment of cancer
JP2708500B2 (ja) 1988-09-27 1998-02-04 三菱電機株式会社 積層形燃料電池
JP2905041B2 (ja) * 1993-07-02 1999-06-14 三菱電機株式会社 メッセージ送受信装置
JPH0720904A (ja) * 1993-07-05 1995-01-24 Toshiba Corp プロセス制御装置のリミッタ設定装置
JP2009102700A (ja) 2007-10-24 2009-05-14 Sumitomo Kinzoku Kozan Siporex Kk 軽量気泡コンクリート補強鉄筋用防錆剤

Also Published As

Publication number Publication date
EP0571485A1 (en) 1993-12-01
LT3184B (en) 1995-03-27
NO932822L (no) 1993-08-09
FI933543A0 (fi) 1993-08-11
HU9302323D0 (en) 1993-10-28
EP0571485B1 (en) 1994-09-14
LTIP298A (en) 1994-08-25
LV10617B (en) 1995-12-20
DK23891D0 (da) 1991-02-12
NO932822D0 (no) 1993-08-09
RO111190B1 (ro) 1996-07-30
CA2100160A1 (en) 1992-08-13
IE66384B1 (en) 1995-12-27
PT100121A (pt) 1993-05-31
HUT68643A (en) 1995-07-28
BR9205624A (pt) 1994-11-08
PL169685B1 (pl) 1996-08-30
IE920436A1 (en) 1992-08-12
FI933543A7 (fi) 1993-08-11
JPH05286950A (ja) 1993-11-02
ES2062891T3 (es) 1994-12-16
DE69200412T2 (de) 1995-02-16
FI933543L (fi) 1993-08-11
CZ163993A3 (en) 1994-01-19
US5405857A (en) 1995-04-11
ATE111455T1 (de) 1994-09-15
BG97988A (bg) 1994-06-30
WO1992013847A1 (en) 1992-08-20
SI9210142A (en) 1995-08-31
SK78993A3 (en) 1994-03-09
LV10617A (lv) 1995-04-20
DE69200412D1 (de) 1994-10-20

Similar Documents

Publication Publication Date Title
EE200000318A (et) Uudsed ühendid
NL970045I2 (nl) Desulfatohirudinen, werkwijze voor hun bereiding en farmaceutische middelen.
NO972451L (no) Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav
DK0397060T3 (da) Maleinimidderivater og deres anvendelse som lægemidler
DE59407237D1 (de) Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
NO965298D0 (no) Ny krystallmodifikasjon av CDCH, fremgangsmåte for fremstilling derav og farmasöytiske preparater inneholdende denne
DK165199C (da) Aktivatorpraeparat, fremgangsmaade til kvantitativ bestemmelse af protein c under anvendelse af praeparatet, antithrombotisk laegemiddel indeholdende praeparatet og fremgangsmaade til udvinding af aktiveret protein c under anvendelse af praeparatet
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
IS1571B (is) Aðferð til framleiðslu á afleiðum tetralíns, cromans og skyldra efnasambanda til meðferðar á asma, liðagigt og skyldum sjúkdómum
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
DK0571485T3 (da) 3-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmåde til fremstilling deraf samt farmaceutisk præparat indeholdende disse forbindelser
ES483661A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
IL88726A0 (en) Dihydrothienobenzodiazepinone derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
DE3874606D1 (de) Behandlung von viraler infektion.
NO883219D0 (no) Framgangsmaate for framstilling av beta-lactam-forbindelse, mellomprodukt for framstilling av denne, og medisinske sammensetninger for behandling av bakteriologiske infeksjonssykdommer inneholdende denne.
DK0808306T3 (da) Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo
DE69008859D1 (de) Modifizierte menschliche anti-rh(d)-antikörper.
NO883285L (no) Fremgangsmaate til fremstilling av leukotrienantagonister.
FR2559157B1 (fr) Nouvel hexapeptide, son procede d'obtention et les compositions pharmaceutiques qui le contiennent
NO883987D0 (no) Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.
NO883674D0 (no) 5-hydroksy-3-aminokroman-forbindelser, fremgangsmaater for deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelsene og metoder for behandling dermed.
MC2013A1 (fr) Methode pour la detection des anticorps diriges contre le virus d'immunodeficience humaine
DK342287D0 (da) Protein med prokoagulerende virkning,fremgangsmaade til fremstilling af et saadant protein og farmaceutisk praeparat indeholdende proteinet